MedPath

A prospective, observational, cohort study of the MASTER-SL Femoral stem in patients with degenerative disease of the hip

Not Applicable
Completed
Conditions
Osteoarthritis
Musculoskeletal - Osteoarthritis
Registration Number
ACTRN12617000550303
Lead Sponsor
The Orthopaedic Institute of Queensland (ORIQL)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

Male and female >18 years;
radiologically confirmed diagnosis of primary osteoarthritis (OS) of the hip and suitable for primary total hip replacement;
Life expectancy of > 10 years
Receiving a MASTER-SL femoral stem
Voluntary written informed consent obtained

Exclusion Criteria

Prospect for recovery to independent mobility compromised by known coexistent, medical problems;
Requiring revision hip replacement;
Loss of abductor musculature, poor bone stock, or poor skin coverage around the hip join;
Previous organ transplant;
Previous hip replacement (resurfacing or THR) on the contra-lateral side within the last 6 months;
Previous hip replacement (resurfacing or THR) on the contralateral side and whose outcome is achieving an Oxford Hip score <18 points;
Body mass index > 40 kg/m2
Active or suspected infection;
Known sensitivity to device materials;
Pregnant woman

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical Outcome Scores: harris Hip Score, [Pre-Operative, 6 weeks post op, 6 months post-op, 1 year post op, 2 year Post op];Outcome score: Oxford Hip [Pre-Operative, 6 weeks post op, 6 months post-op, 1 year post op, 2 year Post op];Outcome score: Non arthritic hip score[Pre-Operative, 6 weeks post op, 6 months post-op, 1 year post op, 2 year Post op]
Secondary Outcome Measures
NameTimeMethod
Outcome Score: EQ5D 5L[Pre-Operative, 6 weeks post op, 6 months post-op, 1 year post op, 2 year Post op];Revision surgery during the observation follow up period due to prosthesis failure[2 year follow up]
© Copyright 2025. All Rights Reserved by MedPath